12/8/2023, 10:24 PM (Source: TeleTrader)
more TeleTrader news

Biden praises FDA's approval of gene editing treatment

United States President Joe Biden issued a formal statement praising the first-ever United States Food and Drug Administration (FDA) approved gene-editing treatment Casgevy, used to treat sickle blood cells.

"As we've seen throughout our history when the US government invests in innovation, we can achieve breakthroughs that would otherwise be impossible," he stated. He called the treatment a "significant medical advancement," which "holds tremendous promise" for developing future life-saving remedies.

"My Administration will continue our efforts to accelerate the development of cures for rare diseases and support the medical research and innovation that achieved this breakthrough," Biden claimed.

Baha Breaking News (BBN) / KA